Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
830 studies found for:    Open Studies | "Connective Tissue Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Connective Tissue Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Undifferentiated Connective Tissue Disease Registry
Condition: Undifferentiated Connective Tissue Disease
Intervention: Other: Observation
2 Recruiting Evaluation and Treatment of Patients With Connective Tissue Disease
Condition: Connective Tissue Disorders
Intervention:
3 Recruiting Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST
Condition: Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
Interventions: Drug: Placebo capsules;   Drug: Bardoxolone methyl capsules
4 Not yet recruiting Efficacy and Safety of Vascana® in Subjects With Secondary Raynaud's Phenomenon
Condition: Raynaud's Phenomenon Secondary to Connective Tissue Disease
Interventions: Drug: Vascana (0.9% nitroglycerin cream);   Drug: Vehicle (placebo)
5 Recruiting Characteristics and Disease Progression of Mixed Connective Tissue Disease and Systemic Lupus Erythematosus
Conditions: Mixed Connective Tissue Disease (MCTD);   Systemic Lupus Erythematosus (SLE)
Intervention:
6 Recruiting Safety and Tolerability of Topically Applied Bovine Lung Surfactant on Intact Skin
Condition: Skin and Connective Tissue Diseases
Interventions: Drug: Surfactants;   Drug: Saline Solution
7 Recruiting Prevalence of Pulmonary Arterial Hypertension in Patients With Connective Tissue Diseases in Egyptian Patients
Conditions: Connective Tissue Diseases;   Pulmonary Hypertension
Intervention:
8 Recruiting Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD
Conditions: Interstitial Lung Disease;   Scleroderma;   Idiopathic Inflammatory Myositis;   Mixed Connective Tissue Disease
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide
9 Recruiting A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects (PREDICTRA)
Conditions: Rheumatoid Arthritis;   Musculoskeletal and Connective Tissue Diseases
Interventions: Drug: Adalimumab;   Other: Placebo
10 Recruiting Determination of Kidney Function
Conditions: Kidney Disease;   Proteinuria;   Autoimmune / Connective Tissue Diseases
Intervention:
11 Not yet recruiting Role of Mesenchymal Stem Cells in Fat Grafting
Conditions: Romberg's Disease;   Craniofacial Microsomia;   Lipodystrophy;   Mixed Connective Tissue Disease
Interventions: Procedure: Fat graft enriched with ex vivo expanded stem cells;   Procedure: Fat graft not enriched with ex vivo expanded stem cells
12 Recruiting Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus
Condition: Active Systemic Lupus Erythematosus
Interventions: Biological: Anifrolumab;   Drug: Placebo
13 Recruiting Employment and Arthritis: Making it Work
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis;   Lupus Erythematosus, Systemic;   Psoriatic Arthritis;   Other Connective Tissue Diseases;   Spondylarthropathy
Intervention: Behavioral: Employment and Arthritis: Making it Work
14 Recruiting Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
Conditions: Scleroderma, Diffuse;   Scleroderma, Systemic;   Scleroderma, Limited;   Sclerosis, Progressive Systemic;   Skin Diseases;   Connective Tissue Diseases;   Pathologic Processes;   Autoimmune Diseases
Interventions: Drug: Oral Ifetroban;   Drug: Oral Placebo
15 Recruiting The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)
Condition: Scleroderma
Intervention:
16 Not yet recruiting SCLERoderma et Adipose-DErived Stroma Cells
Condition: Systemic Sclerosis
Interventions: Drug: Stromal Vascular fraction;   Drug: Ringer lactate
17 Recruiting Duke Scleroderma Clinic Patient Registry
Conditions: Scleroderma;   Systemic Sclerosis
Intervention: Other: Registry
18 Recruiting Novel Rehabilitation Strategies to Improve Arm Function in Patients With Scleroderma
Conditions: Scleroderma;   Ssc
Intervention: Other: Occupational therapy treatment
19 Recruiting A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis
Condition: Scleroderma, Systemic
Interventions: Drug: Nintedanib;   Drug: Placebo
20 Not yet recruiting Tissue Sodium in Autoimmune Disease
Condition: Systemic Lupus Erythematosus
Interventions: Dietary Supplement: Low Dietary Sodium;   Dietary Supplement: High Dietary Sodium

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.